Interleukin-1 is not essential for expression of inducible NOS in hepatocytes induced by lipopolysaccharide in vivo

Nitric Oxide - Biology and Chemistry

Volumn 16, Issue 4, 2007, Pages 433-441

  Takagi, Kunio ^a   Matsumura, Shinji ^a   Okuda Ashitaka, Emiko ^a   Okuda, Kazuyuki ^a   Watanabe, Jun ^a   Takahashi, Hakuo ^a   Iwakura, Yoichiro ^b   Ito, Seiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Interleukin 1; Knockout mice; Kupffer cells; Lipopolysaccharide; Nitric oxide; Toll like receptor 4; Tumor necrosis factor

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRATE; NITRIC OXIDE; NITRITE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; KUPFFER CELL; LIVER CELL; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; HEPATOCYTES; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 34249706321     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2007.03.005     Document Type: Article

References (35)

1. Thiemermann C., and Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182 (1990) 591-595
2. Petros A., Bennett D., and Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338 (1991) 1557-1558
3. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87 (1990) 3629-3632
4. Hewett J.A., and Roth R.A. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev. 45 (1993) 382-411
5. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192 (1990) 245-261
6. Chensue S.W., Terebuh P.D., Remick D.G., Scales W.E., and Kunkel S.L. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Am. J. Pathol. 138 (1991) 395-402
7. Luster M.I., Germolec D.R., Yoshida T., Kayama F., and Thompson M. Endotoxin- induced cytokine gene expression and excretion in the liver. Hepatology 19 (1994) 480-488
8. Evans T.J., Strivens E., Carpenter A., and Cohen J. Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous gram-negative infection. J. Immunol. 150 (1993) 5033-5040
9. Dinarello C.A. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis. 163 (1991) 1177-1184
10. Lewis M., Tartaglia L.A., Lee A., Bennett G.L., Rice G.C., Wong G.H., Chen E.Y., and Goeddel D.V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88 (1991) 2830-2834
11. Ohlsson K., Björk P., Bergenfeldt M., Hageman R., and Thompson R.C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348 (1990) 550-552
12. Wakabayashi G., Gelfand J.A., Burke J.F., Thompson R.C., and Dinarello C.A. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5 (1991) 338-343
13. Beutler B., Milsark I.W., and Cerami C.A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229 (1985) 869-871
14. Russell D.A., Tucker K.K., Chinookoswong N., Thompson R.C., and Kohno T. Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function. J. Infect. Dis. 171 (1995) 1528-1538
15. Salkowski C.A., Neta R., Wynn T.A., Strassmann G., van Rooijen N., and Vogel S.N. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J. Immunol. 155 (1995) 3168-3179
16. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.S., Kronke M., and Mak T.W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457-467
17. Salkowski C.A., Detore G., McNally R., van Rooijen N., and Vogel S.N. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo. J. Immunol. 158 (1997) 905-912
18. Geller D.A., de Vera M.E., Russell D.A., Shapiro R.A., Nussler A.K., Simmons R.L., and Billiar T.R. A central role for IL-1β in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. J. Immunol. 155 (1995) 4890-4898
19. Kitade H., Sakitani K., Inoue K., Masu Y., Kawada N., Hiramatsu Y., Kamiyama Y., Okumura T., and Ito S. Interleukin 1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 23 (1996) 797-802
20. Horai R., Asano M., Sudo K., Kanuka H., Suzuki M., Nishihara M., Takahashi M., and Iwakura Y. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187 (1998) 1463-1475
21. -/- mice: role for IFN-γ in activating apoptosis of hepatocytes. J. Immunol. 159 (1997) 1418-1428
22. Braman R.S., and Hendrix S.A. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal. Chem. 61 (1989) 2715-2718
23. Nakauchi T., Ando A., Ueda-Yamada M., Yamazaki Y., Uyama M., Matsumura M., and Ito S. Prevention of ornithine cytotoxicity by nonpolar side chain amino acids in retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 44 (2003) 5023-5028
24. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162 (1999) 3749-3752
25. Curran R.D., Billiar T.R., Stuehr D.J., Hofmann K., and Simmons R.L. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J. Exp. Med. 170 (1989) 1769-1774
26. Kurose I., Miura S., Higuchi H., Watanabe N., Kamegaya Y., Takaishi M., Tomita K., Fukumura D., Kato S., and Ishii H. Increased nitric oxide synthase activity as a cause of mitochondrial dysfunction in rat hepatocytes: roles for tumor necrosis factorα. Hepatology 24 (1996) 1185-1192
27. Geller D.A., Nussler A.K., Di Silvio M., Lowenstein C.J., Shapiro R.A., Wang S.C., Simmons R.L., and Billiar T.R. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA 90 (1993) 522-526
28. Oguro T., Takahashi Y., Ashino T., Takaki A., Shioda S., Horai R., Asano M., Sekikawa K., Iwakura Y., and Yoshida T. Involvement of tumor necrosis factorα, rather than interleukin-1α/β or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver. FEBS Lett. 516 (2002) 63-66
29. Qureshi S.T., Gros P., and Malo D. Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes. Trends Genet. 15 (1999) 291-294
30. Barnes P.J., and Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
31. Cao Z., Xiong J., Takeuchi M., Kurama T., and Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature 383 (1996) 443-446
32. Muzio M., Natoli G., Saccani S., Levrero M., and Mantovani A. The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187 (1998) 2097-2101
33. Hsu H., Shu H.B., Pan M.G., and Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84 (1996) 299-308
34. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., and Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143-150
35. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 (1999) 115-122